clarithromycin Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New Trials
Online Trials
Age Group

Any (3)

Phase 1/2 (1)
Phase 3 (2)

Interventional (3)

Nicolaas Bohnen, MD, PhD (1)
Tanta University (1)
The First Affiliated Hospital of Soochow University (1)

No (3)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadhelicobacter pylori

I am/have/hadmultiple myeloma

I am/have/hadhelicobacter infection

I am/have/hadejection fraction

I am/have/hadspinal cord

I am/have/hadstroke

I am/have/hadparkinson's disease

I am/have/hadanxiety

I am/have/hadcellular therapy

I am/have/hadcar t-cell therapy

I am/have/hadparkinsonism

I am/have/haddementia

I am/have/hadpositron emission tomography

I am/have/hadbrain imaging

I am/have/hadcochlear implant

I am/have/hadserum pregnancy test

added new label for I am/have/had

I am looking for

I am looking forclarithromycin

I am looking formetronidazole

I am looking fordexamethasone

I am looking forproton pump inhibitors

I am looking forlenalidomide

I am looking fornitazoxanide

I am looking forantipsychotics

I am looking forbenztropine

I am looking forbcma

I am looking forcholinesterase inhibitors

I am looking foranticholinergics

I am looking forantidepressants

I am looking formodafinil

I am looking fortrihexyphenidyl

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm

The arm of this study evaluates possible GABA-A receptor target engagement effects of the FDA-approved medication, transdermal flumazenil (added 4/2020, replaced clarithromycin), in the setting of Parkinson's disease. Half of the subjects will receive transdermal flumazenil for 7-10 days, and half will receive a placebo. [11C]Flumazenil GABA-A receptor PET imaging …

spinal cord

antipsychotics

parkinson's disease

benztropine

cholinesterase inhibitors

0 views
19 Feb, 2024
1 location

Phase 3
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

helicobacter pylori

helicobacter infection

proton pump inhibitors

clarithromycin

nitazoxanide

0 views
19 Feb, 2024
1 location

Phase 3
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients

bcma

cellular therapy

dexamethasone

multiple myeloma

lenalidomide

0 views
19 Feb, 2024
1 location